The monitoring of drug safety to identify potential adverse drug reactions (ADRs) as early as possible to keep the number of affected individuals to a minimum has been a public health concern since the thalidomide tragedy at the beginning of the 1960s. At the national level, the typical postmarketing surveillance method is the voluntary reporting […]